Login to Your Account

FDA Plans Oversight Changes At Drug Manufacturing Facilities

By Kim Coghill

Friday, August 23, 2002
WASHINGTON - The FDA intends to catch up with advancing technology and science by implementing a plan to upgrade its system of monitoring the manufacturing facilities that make biologics, drugs and veterinarian products. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription